Tested Applications
| Positive WB detected in | PC-3 cells, mouse brain tissue, mouse large intestine tissue, mouse ovary tissue, mouse skeletal muscle tissue |
| Positive IHC detected in | human colon cancer tissue, human ovary tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20330-1-AP targets B4GALT2 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag14046 Product name: Recombinant human B4GALT2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 60-176 aa of BC002431 Sequence: PGVLMGGRYTPPDCTPAQTVAVIIPFRHREHHLRYWLHYLHPILRRQRLRYGVYVINQHGEDTFNRAKLLNVGFLEALKEDAAYDCFIFSDVDLVPMDDRNLYRCGDQPRHFAIAMD Predict reactive species |
| Full Name | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 |
| Calculated Molecular Weight | 372 aa, 42 kDa |
| Observed Molecular Weight | 42-45 kDa |
| GenBank Accession Number | BC002431 |
| Gene Symbol | B4GALT2 |
| Gene ID (NCBI) | 8704 |
| RRID | AB_10693615 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O60909 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for B4GALT2 antibody 20330-1-AP | Download protocol |
| WB protocol for B4GALT2 antibody 20330-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The B4GALT2 Polyclonal antibody (Cat# 20330-1-AP) has 2 citations. One appeared in Journal for ImmunoTherapy of Cancer (IF 11.7), studying B4GALT2 as an immune exclusion regulator in lung adenocarcinoma via IHC. The other was published in Frontiers in Genetics (IF 3), identifying a glycosyltransferase prognostic signature in hepatocellular carcinoma using WB. Both studies were conducted in human samples, covering research fields of cancer immunology and oncology biomarker discovery.
| Species | Application | Title |
|---|---|---|
J Immunother Cancer Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma | ||
Front Genet Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm. |





















